Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Gils

Showing results (111-120 of 162) with videos related to

Pageof 17
Sort By:
Inflammatory Bowel Diseases|August 28, 2015
The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis ProfileLize Bollen, Niels Vande Casteele, Miet Peeters, et al.
Thrombosis and Haemostasis|July 31, 2003
Biochemical importance of glycosylation of plasminogen activator inhibitor-1Ann Gils, Katrine E Pedersen, Peter Skottrup, et al.
The Journal of Investigative Dermatology|May 9, 2019
Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis: A Step toward Personalized TherapyRani Soenen, Evelyn Meulewaeter, Lynda Grine, et al.
The Journal of Biological Chemistry|December 18, 2008
The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complexChengliang Wu, Paul Y Kim, Reg Manuel, et al.
Inflammatory Bowel Diseases|May 13, 2017
Infliximab Trough Levels at Induction to Predict Treatment Failure During MaintenanceClaire Liefferinckx, Charlotte Minsart, Jean-François Toubeau, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2019
Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's diseaseBram Verstockt, Sare Verstockt, Brecht Creyns, et al.
Gastroenterology|March 1, 2015
Trough concentrations of infliximab guide dosing for patients with inflammatory bowel diseaseNiels Vande Casteele, Marc Ferrante, Gert Van Assche, et al.
Inflammatory Bowel Diseases|February 7, 2015
Short-term effect of infliximab is reflected in the clot lysis profile of patients with inflammatory bowel disease: a prospective studyLize Bollen, Niels Vande Casteele, Miet Peeters, et al.
Plos One|May 5, 2017
Inhibition of plasmin-mediated TAFI activation may affect development but not progression of abdominal aortic aneurysmsKatherine Bridge, Charlotte Revill, Fraser Macrae, et al.
European Journal of Gastroenterology & Hepatology|January 24, 2019
Early vedolizumab trough levels at induction in inflammatory bowel disease patients with treatment failure during maintenanceClaire Liefferinckx, Charlotte Minsart, Anneline Cremer, et al.
Pageof 17

Showing results (111-120 of 162) with videos related to

Sort By:
Pageof 17
Inflammatory Bowel Diseases|August 28, 2015
The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis ProfileLize Bollen, Niels Vande Casteele, Miet Peeters, et al.
Thrombosis and Haemostasis|July 31, 2003
Biochemical importance of glycosylation of plasminogen activator inhibitor-1Ann Gils, Katrine E Pedersen, Peter Skottrup, et al.
The Journal of Investigative Dermatology|May 9, 2019
Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis: A Step toward Personalized TherapyRani Soenen, Evelyn Meulewaeter, Lynda Grine, et al.
The Journal of Biological Chemistry|December 18, 2008
The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complexChengliang Wu, Paul Y Kim, Reg Manuel, et al.
Inflammatory Bowel Diseases|May 13, 2017
Infliximab Trough Levels at Induction to Predict Treatment Failure During MaintenanceClaire Liefferinckx, Charlotte Minsart, Jean-François Toubeau, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2019
Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's diseaseBram Verstockt, Sare Verstockt, Brecht Creyns, et al.
Gastroenterology|March 1, 2015
Trough concentrations of infliximab guide dosing for patients with inflammatory bowel diseaseNiels Vande Casteele, Marc Ferrante, Gert Van Assche, et al.
Inflammatory Bowel Diseases|February 7, 2015
Short-term effect of infliximab is reflected in the clot lysis profile of patients with inflammatory bowel disease: a prospective studyLize Bollen, Niels Vande Casteele, Miet Peeters, et al.
Plos One|May 5, 2017
Inhibition of plasmin-mediated TAFI activation may affect development but not progression of abdominal aortic aneurysmsKatherine Bridge, Charlotte Revill, Fraser Macrae, et al.
European Journal of Gastroenterology & Hepatology|January 24, 2019
Early vedolizumab trough levels at induction in inflammatory bowel disease patients with treatment failure during maintenanceClaire Liefferinckx, Charlotte Minsart, Anneline Cremer, et al.
Pageof 17